骨髓增殖性肿瘤中西医诊治研究进展

Advances in the Diagnosis and Treatment of Myeloproliferative Neoplasms with Traditional Chinese and Western Medicine

骨髓增殖性肿瘤(myeloproliferative neoplasms, MPN)是起源于造血干细胞的恶性骨髓增殖性疾病。经典的BCR-ABL阴性MPN包括真性红细胞增多症,原发性血小板增多症,原发性骨髓纤维化。大部分患者存在驱动基因突变,遗传学改变与其发病机制尚未明确,因此缺乏精准化治疗方案,且目前西医治疗效果不理想,不良反应多,而中西医联合治疗效果优于单用现代医学治疗,在缓解患者临床症状和减轻西医治疗不良反应方面存在一定优势。本文对近年来MPN的中西医病因病机及其治疗作一综述。

Myeloproliferative neoplasms (MPN) are clonal hematologic malignancies, which are arisen from mutanthematopoietic stem. Classical BCR-ABL negative MPNs include polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Most patients have driver gene mutations, genetic change and its pathogenesis has not yet been clear, so the lack of precision treatment plan, and the current western medicine treatment effect is not ideal, has multiple adverse reactions. While the combined Chinese and western medicine treatment effect is better than single modern medical treatment, and has certain advantages reducing in clinical symptoms and western medicine treat-ment adverse reactions of patients. This review summarizes the etiology and pathogenesis and treatment of MPN in Traditional Chinese and Western medicine in recent years.